These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23728406)

  • 1. Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
    Farhat MR; Loring SH; Riskind P; Weinhouse G
    Eur Respir J; 2013 Jun; 41(6):1454-6. PubMed ID: 23728406
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuromuscular diseases in adults: which respiratory muscle explorations for what type of management?].
    Lofaso F; Prigent H; Orlikowski D; Trebbia G; Lejaille M; Falaize L; Louis A; Ruquet M; Raphaël JC
    Rev Mal Respir; 2005 Feb; 22(1 Pt 2):2S78-85. PubMed ID: 15968800
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary function in multiple sclerosis without any respiratory complaints.
    Altintas A; Demir T; Ikitimur HD; Yildirim N
    Clin Neurol Neurosurg; 2007 Apr; 109(3):242-6. PubMed ID: 17046152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment in a case of respiratory myoclonus].
    Pardal-Fernández JM; García-Muñozguren S; Hermida-Lazcano I; Perona-Moratalla AB
    Rev Neurol; 2006 Dec 1-15; 43(11):699-700. PubMed ID: 17133332
    [No Abstract]   [Full Text] [Related]  

  • 5. Respiratory changes in multiple sclerosis.
    Karpatkin H
    J Neurol Phys Ther; 2008 Jun; 32(2):105. PubMed ID: 18645300
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
    Carvalho SR; Alvarenga Filho H; Papais-Alvarenga RM; Chacur FH; Dias RM
    Respirology; 2012 Jul; 17(5):869-75. PubMed ID: 22564062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early respiratory evaluation should be carried out systematically in patients with multiple sclerosis.
    Taveira FM; Teixeira AL; Domingues RB
    Arq Neuropsiquiatr; 2013 Mar; 71(3):142-5. PubMed ID: 23563712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The usefulness of the Peak Flow Meter for assessing patients with acute respiratory disease].
    Alvarez Torices JC; Diego Domínguez F; Franch Nadal J; Alvarez Guisasola F; Pablo Pons ML
    An Med Interna; 1990 Nov; 7(11):570-4. PubMed ID: 2103210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized control trial of effects of a 10-week inspiratory muscle training program on measures of pulmonary function in persons with multiple sclerosis.
    Fry DK; Pfalzer LA; Chokshi AR; Wagner MT; Jackson ES
    J Neurol Phys Ther; 2007 Dec; 31(4):162-72. PubMed ID: 18172412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of dyspnea in patients with amyotrophic lateral sclerosis.
    Lechtzin N; Lange DJ; Davey C; Becker B; Mitsumoto H
    Muscle Nerve; 2007 Jan; 35(1):98-102. PubMed ID: 17029274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffective breathing pattern related to respiratory muscle fatigue.
    Larson JL; Kim MJ
    Nurs Clin North Am; 1987 Mar; 22(1):207-23. PubMed ID: 3547343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of relapsing remitting-multiple sclerosis. Prognostic factors].
    Fernández-Fernández O
    Rev Neurol; 2002 Dec 1-15; 35(11):1067-73. PubMed ID: 12497314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis.
    Coret F; Bosca I; Landete L; Magraner MJ; Navarré A; León JL; Casanova B
    Mult Scler; 2010 Aug; 16(8):935-41. PubMed ID: 20573640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipsilateral silent period: a marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?
    Jung P; Beyerle A; Humpich M; Neumann-Haefelin T; Lanfermann H; Ziemann U
    J Neurol Sci; 2006 Dec; 250(1-2):133-9. PubMed ID: 17011585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
    Zellini F; Niepel G; Tench CR; Constantinescu CS
    Mult Scler; 2009 Dec; 15(12):1442-9. PubMed ID: 19995847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting state networks change in clinically isolated syndrome.
    Roosendaal SD; Schoonheim MM; Hulst HE; Sanz-Arigita EJ; Smith SM; Geurts JJ; Barkhof F
    Brain; 2010 Jun; 133(Pt 6):1612-21. PubMed ID: 20356855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic studies on respiratory diseases in Płock. IV. Selected environmental factors and symptoms of chronic non-specific respiratory diseases].
    Szczuka I; Leowski J; Miller M; Werens S
    Pneumonol Pol; 1978 Sep; 46(9):647-53. PubMed ID: 704369
    [No Abstract]   [Full Text] [Related]  

  • 18. The irregularly irregular pattern of respiratory dyskinesia.
    Kuna ST; Awan R
    Chest; 1986 Nov; 90(5):779-81. PubMed ID: 3769590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.